CompletedNCT06388694
Official study titlePharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests: A Randomized Clinical Trial
This study has finished and is no longer accepting participants.
In OaklandADHDInterventional studyAges 2–17
- Countries
- United States
- Sponsor
- Kaiser Permanente
TerminatedNCT03730870
Official study titleAssessment of Pharmacogenomics Testing for Improving Pediatric ADHD Psychopharmacological Treatment: A Randomized Controlled Trial
This study ended early.
Multiple locations, including HamiltonADHDStudy assessmentsAges 6–18
- Countries
- United States
- Sponsor
- Clinical and Translational Genome Research Institute, Inc.
CompletedNCT05200936
What is this study about?Researchers compared MM120 and placebo, tracking side effects to assess safety in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including MaastrichtADHDMedication studyAges 18–65
- Countries
- Switzerland, Netherlands
- Sponsor
- Definium Therapeutics US, Inc.
CompletedNCT03945175
What is this study about?This study evaluated the effectiveness of MYDAYIS for people with ADHD.
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 18–60
- Countries
- United States
- Sponsor
- NYU Langone Health
UnknownNCT06594536
Official study titleStudy of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity
Current recruitment status is unconfirmed.
Location not clearly listedADHDPlacebo comparisonAges 6–12
- Countries
- Sponsor
- Assistance Publique - Hôpitaux de Paris
TerminatedNCT05219370
Official study titleTreatment With Cannabis Oil Containing Canabidiol (CBD) Tetrahydrocannabinol (THC), Cannabidivarin (CBDV) or Cannabigerol (CBG) vs. Placebo of Persons Diagnosed With ADHD After Failure of Conventional Treatment
This study ended early.
In Be’er Ya‘aqovADHDMedication studyAges 18+
- Countries
- Israel
- Sponsor
- Brlev Agricultural Crops Ltd
Active Not RecruitingNCT07126899
Official study titleHand Tendon Injuries: Investigation of Attention Deficit, Hyperactivity, Impulsivity, Anger, and Anxiety Levels - Case-Control Study
This study is no longer accepting new participants.
In YozgatADHDObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Atılım University
WithdrawnACTRN12617000156381
Official study titleCurcumin supplementation for the treatment of attention and impulsivity problems in children and adolescents – a randomised, double-blind, placebo-controlled, crossover study
This study was withdrawn before enrollment.
In AustraliaADHDInterventional studyAges 8–14
- Countries
- Australia
- Sponsor
- Murdoch University
Not recruitingISRCTN71041318
This study isn't currently recruiting.
In SpainADHDResearch studyAges 8–11
- Countries
- Spain
- Sponsor
- Sincrolab Ltd
Not recruitingISRCTN61683087
This study isn't currently recruiting.
In SudanADHDResearch studyAges 6–15
- Countries
- Sudan, Suriname, Türkiye
- Sponsor
- Istanbul University
Not recruitingISRCTN13078441
This study isn't currently recruiting.
In NetherlandsADHDResearch studyAges 12–18
- Countries
- Netherlands
- Sponsor
- Maasstad Hospital Rotterdam (Maasstadziekenhuis Rotterdam)
Not recruitingISRCTN99820028
This study isn't currently recruiting.
In United KingdomADHDResearch studyUp to 20 months
- Countries
- United Kingdom
- Sponsor
- University of Oxford (University)